The National Medical Products Administration (NMPA) approved four new products for test of new coronavirus on Sunday, 26 January.
The products, including reagent test kits and sequencing system of the virus, are expected to speed up the diagnosis process and further expand the supply capacity of virus detection products.
Meanwhile, the NMPA urged provincial drug regulators to intensify the supervision on production to ensure product safety.
The administration said it will continue implementing special approval procedures for drugs and medical devices to contain the outbreak.
(This story was auto-published from a syndicated feed. No part of the story has been edited by FIT .)
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)